Genitope Corp Performance

The etf retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Genitope Corp are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Genitope Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Genitope Corp is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
  

Genitope Corp Relative Risk vs. Return Landscape

If you would invest (100.00) in Genitope Corp on November 21, 2025 and sell it today you would earn a total of  100.00  from holding Genitope Corp or generate -100.0% return on investment over 90 days. Genitope Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Genitope, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Genitope Corp Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genitope Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genitope Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Genitope Corp is not yet fully synchronised with the market data
Genitope Corp has some characteristics of a very speculative penny stock
Genitope Corp has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (104.1 M).
Genitope Corp currently holds about 12.4 M in cash with (38.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Roughly 19.0% of the company shares are held by company insiders

Genitope Corp Fundamentals Growth

Genitope Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Genitope Corp, and Genitope Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genitope Pink Sheet performance.
Genitope Corp is not yet fully synchronised with the market data
Genitope Corp has some characteristics of a very speculative penny stock
Genitope Corp has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (104.1 M).
Genitope Corp currently holds about 12.4 M in cash with (38.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Roughly 19.0% of the company shares are held by company insiders
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Genitope Pink Sheet

If you are still planning to invest in Genitope Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genitope Corp's history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories